VH

Vyome Holdings, Inc.

HIND·NASDAQ

$5.73

+14%
HealthcareBiotechnology

Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets. The company was founded in 2017 and is based in Princeton, New Jersey.

At a Glance

Live Snapshot
Market Cap$151.09M
EPS-345.7400
P/E Ratio-1.29
Earnings Date05/18/2026

HIND

Other Liabilities

Last Annual Value

0.00

3-Year CAGR

%

5-Year CAGR

%

10-Year CAGR

%

Failed to load chart data

VH

Vyome Holdings, Inc. Competitors Analysis of other-liabilities

HIND · NASDAQ
Companyother-liabilities
CAGR 3Y
CAGR 5Y
CAGR 10Y

No comparison data available

We couldn't find other-liabilities data for this stock's competitors.

VH

Vyome Holdings, Inc. Fair Value Envelope

HIND · NASDAQ

Our analysis suggests that HIND has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $5.73, this represents a potential HIDDEN relative to our calculated worth for Vyome Holdings, Inc..

Intrinsic Value
Current Price: $5.73